Press release
Dalteparin Sodium Market 2016 - Pfizer (USA), Reliable Biopharmaceutical (USA), Gland Pharma (India), Opocrin (Italy), Hebei Changshan (China), Changzhou Qianhong (China)
Dalteparin is a low molecular weight heparin. It is marketed as Fragmin by Pfizer Inc. Like other low molecular weight heparins, dalteparin is used for prophylaxis or treatment of deep vein thrombosis and pulmonary embolism. It is normally administered by self-injection.Heparins are cleared by the kidneys, but studies have shown that dalteparin does not accumulate even if kidney function is reduced.
Major players in the global Dalteparin Sodium market :-
Pfizer (USA)
Reliable Biopharmaceutical (USA)
Gland Pharma (India)
Opocrin (Italy)
Hebei Changshan (China)
Changzhou Qianhong (China)
Nanjing Kingfriend (China)
REQUEST FOR SAMPLE @ https://goo.gl/oo4FNK
This report provides detailed analysis of worldwide markets for Dalteparin Sodium from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and sub sectors. It covers the key technological and market trends in the Dalteparin Sodium market and further lays out an analysis of the factors influencing the supply/demand for Dalteparin Sodium, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
Global Dalteparin Sodium Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Dalteparin Sodium market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players.
The CLOT study, published in 2003, showed that in patients with malignancy and acute venous thromboembolism, dalteparin was more effective than warfarin in reducing the risk of recurrent embolic events. Dalteparin is not superior to unfractionated heparin in preventing blood clots.
Browse full report with TOC : http://marketinsights.biz/global-dalteparin-sodium-market-outlook-2016-2021/
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Dalteparin Sodium industry has been provided.
"MarketInsights.Biz” offer reports from top publishers and update to serve you with immediate on-line access to professional insights on global industries, companies, products, and trends. Customers can buys different reports across various categories such as Chemical and Material, Biotechnology, Healthcare, Food and beverages, Automobile and various sectors. Our Website offers safe and secure online ordering experience, convenient payment options.
Contact US:
Frank Valadez
Director of Business Development
Website: http://marketinsights.biz/
Email:sales@marketinsights.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dalteparin Sodium Market 2016 - Pfizer (USA), Reliable Biopharmaceutical (USA), Gland Pharma (India), Opocrin (Italy), Hebei Changshan (China), Changzhou Qianhong (China) here
News-ID: 381948 • Views: …
More Releases from Industry Research
Spinal Cord Stimulation Devices Market Report 2019 with Universal Growth Analysi …
Global "Spinal Cord Stimulation Devices" Market Report gives complete framework data on market definition, research methodology, current scenario, dynamics, major conclusions, market Segmentation by technology, product types, application and geography. Spinal Cord Stimulation Devices market report also covers a study on the competitive landscape which describes mergers and acquisition. And also provides analysis on agreements, collaborations, and partnerships between leading key players in Spinal Cord Stimulation Devices market growth.
Get a…

Global Artificial Intelligence Platforms Market Size & Outlook 2023: Details for …
Global “Artificial Intelligence Platforms Market” report offers a specified analysis of the different patterns and parameters affecting the development of the global Artificial Intelligence Platforms market. The report also delivers an assessment of the effect of the current patterns in the market including the other essential information about the market’s future development. The report comprises detailed information relating to the growth factors of the Artificial Intelligence Platforms market and also…

Compact Type Spark Plugs Market Analysis, Growth, Industry Outlook and Forecast …
The Global “Compact Type Spark Plugs Market” Report presents a strong perspective on market size, market scope, and competitive environment for conclusions and research. This study is derived from primary and secondary statistical data and includes qualitative and numerical analysis. Compact Type Spark Plugs market research focuses on the key influences prevailing in the global Compact Type Spark Plugs industry. An existing Compact Type Spark Plugs market scenario has been…

Surgical Aspiration & Irrigation Suction Pumps Market In-Depth Analysis – By M …
The Global “Surgical Aspiration & Irrigation Suction Pumps Market” Report presents a strong perspective on market size, market scope, and competitive environment for conclusions and research. This study is derived from primary and secondary statistical data and includes qualitative and numerical analysis. Surgical Aspiration & Irrigation Suction Pumps market research focuses on the key influences prevailing in the global Surgical Aspiration & Irrigation Suction Pumps industry. An existing Surgical Aspiration…
More Releases for Dalteparin
USD 3.5 Billion Dalteparin Sodium Market by 2033: Trends, Forecast & CAGR 5.71%
The global Dalteparin Sodium Market was valued at approximately USD 320 million in 2024 and is projected to reach around USD 530 million by 2033, growing at a compound annual growth rate (CAGR) of about 6.0% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/dalteparin-sodium-market
Dalteparin Sodium Market Overview:
The Dalteparin Sodium Market is experiencing steady growth driven by the increasing prevalence of thromboembolic disorders such as deep vein…
Global Dalteparin Sodium Market - Industry Trends and Forecast to 2032
The global dalteparin sodium market was valued at approximately USD 1.1 billion in 2023 and is projected to reach around USD 1.8 billion by 2032, reflecting a compound annual growth rate (CAGR) of about 5.9% from 2024 to 2032.
Global Dalteparin Sodium Market Overview
The global dalteparin sodium market is witnessing steady growth, driven by the increasing prevalence of deep vein thrombosis (DVT), pulmonary embolism, and other thrombotic disorders. Dalteparin…
Dalteparin Sodium Market Analysis, Size, Current Scenario and Future Prospects
Dalteparin Sodium Market is estimated to grow at a CAGR of XX% during the forecast period. Dalteparin is a drug that is used to treat and prevent dangerous blood clots. Preventing dangerous blood clots can help you avoid a stroke or heart attack. Dalteparin helps in the smooth flow of blood, by reducing the activity of clotting proteins in the blood. It is commonly known as blood thinner which is heparin…
Global Dalteparin Sodium Market Research Report 2017
Report Hive Market Research Released a New Research Report of 115 pages on Title " Global Dalteparin Sodium Market Research Report 2017 "with detailed Analysis, Forecast and Strategies.
In this report, the global Dalteparin Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented…
Global Dalteparin Sodium Market 2016 - Pfizer, Gland Pharma, Opocrin, Hebei Chan …
The report that is written on the title Dalteparin Sodium Market 2016 covers all the aspects of the global market study. This report has an estimation about the Dalteparin Sodium Market size in terms of value (US$). The report contains the broad segmentation of the market. The report provides the information about the Dalteparin Sodium Market and also forecasts its position in the coming years.
Dalteparin is a low molecular…
2017 United States Dalteparin Sodium Market Report
In this report, the United States Dalteparin Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Request Free Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1032376
Geographically, this report splits the United States market into six regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales…